XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
License and Collaboration Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2020
Sep. 30, 2022
Sep. 30, 2021
Research and License Agreements            
Revenue from collaboration and license agreements   $ 86,560   $ 75,000 $ 1,142,142
Apollomics, Inc.            
Research and License Agreements            
Revenue from collaboration and license agreements           $ 1,100,000
Up-front payment received       $ 9,000,000.0    
Milestones based on achievement of certain clinical and regulatory events       75,000,000.0    
Milestone payment upon achievement of specified net sales thresholds for all licensed products       $ 105,000,000.0    
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0          
Apollomics, Inc. | Maximum            
Research and License Agreements            
Tiered percentage of annual net sales       15.00%